» Articles » PMID: 20375170

Hepatitis C Virus Transmission Bottlenecks Analyzed by Deep Sequencing

Overview
Journal J Virol
Date 2010 Apr 9
PMID 20375170
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis C virus (HCV) replication in infected patients produces large and diverse viral populations, which give rise to drug-resistant and immune escape variants. Here, we analyzed HCV populations during transmission and diversification in longitudinal and cross-sectional samples using 454/Roche pyrosequencing, in total analyzing 174,185 sequence reads. To sample diversity, four locations in the HCV genome were analyzed, ranging from high diversity (the envelope hypervariable region 1 [HVR1]) to almost no diversity (the 5' untranslated region [UTR]). For three longitudinal samples for which early time points were available, we found that only 1 to 4 viral variants were present, suggesting that productive infection was initiated by a very small number of HCV particles. Sequence diversity accumulated subsequently, with the 5' UTR showing almost no diversification while the envelope HVR1 showed >100 variants in some subjects. Calculation of the transmission probability for only a single variant, taking into account the measured population structure within patients, confirmed initial infection by one or a few viral particles. These findings provide the most detailed sequence-based analysis of HCV transmission bottlenecks to date. The analytical methods described here are broadly applicable to studies of viral diversity using deep sequencing.

Citing Articles

Update on Hepatitis C Vaccine: Results and Challenges.

Garbuglia A, Pauciullo S, Zulian V, Del Porto P Viruses. 2024; 16(8).

PMID: 39205311 PMC: 11359353. DOI: 10.3390/v16081337.


Cross-scale dynamics and the evolutionary emergence of infectious diseases.

Schreiber S, Ke R, Loverdo C, Park M, Ahsan P, Lloyd-Smith J Virus Evol. 2022; 7(1):veaa105.

PMID: 35186322 PMC: 8087961. DOI: 10.1093/ve/veaa105.


Validation of a Genotype-Independent Hepatitis C Virus Near-Whole Genome Sequencing Assay.

Lapointe H, Dong W, Dong W, Kirkby D, Woods C, Poon A Viruses. 2021; 13(9).

PMID: 34578305 PMC: 8473162. DOI: 10.3390/v13091721.


Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs.

Montoya V, Howe A, Dong W, Dong W, Brumme C, Olmstead A Sci Rep. 2021; 11(1):9986.

PMID: 33976241 PMC: 8113533. DOI: 10.1038/s41598-021-88132-8.


CpG-creating mutations are costly in many human viruses.

Caudill V, Qin S, Winstead R, Kaur J, Tisthammer K, Pineda E Evol Ecol. 2020; 34(3):339-359.

PMID: 32508375 PMC: 7245597. DOI: 10.1007/s10682-020-10039-z.


References
1.
Hoffmann C, Minkah N, Leipzig J, Wang G, Arens M, Tebas P . DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations. Nucleic Acids Res. 2007; 35(13):e91. PMC: 1934997. DOI: 10.1093/nar/gkm435. View

2.
Schloss P, Handelsman J . Introducing DOTUR, a computer program for defining operational taxonomic units and estimating species richness. Appl Environ Microbiol. 2005; 71(3):1501-6. PMC: 1065144. DOI: 10.1128/AEM.71.3.1501-1506.2005. View

3.
Netski D, Mao Q, Ray S, Klein R . Genetic divergence of hepatitis C virus: the role of HIV-related immunosuppression. J Acquir Immune Defic Syndr. 2008; 49(2):136-41. PMC: 3071283. DOI: 10.1097/QAI.0b013e3181869a6f. View

4.
Hoofnagle J . A step forward in therapy for hepatitis C. N Engl J Med. 2009; 360(18):1899-901. DOI: 10.1056/NEJMe0901869. View

5.
Sherman K, Rouster S, Chung R, Rajicic N . Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002; 34(6):831-7. DOI: 10.1086/339042. View